ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,756
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
Author(s):
RB Lipton
,
PJ Goadsby
,
J. SMITH
,
BA Schaeffler
,
DM Biondi
,
J Hirman
Publication date:
2020
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Efficacy of Communicating Science
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
2,756
A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of eptinezumab in frequent episodic migraine prevention: primary results of the PROMISE 1 (PRevention Of Migraine via Intravenous eptinezumab Safety and Efficacy 1) Trial
Authors:
J. Saper
,
R Lipton
,
D Kudrow
Vyepti (eptinezumab-jjmr) prescribing information
Authors:
Lundbeck reports positive results for Vyepti[®] (eptinezumab) from the DELIVER study in patients with migraine and prior preventive treatment failures
Authors:
See all similar